drugset / Trial / NCT00352664

The Effect of Donepezil on Sedation and Other Symptoms

NCT00352664

Phase 3 Terminated 27 enrolled M.D. Anderson Cancer Center Pfizer · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Primary Objective: 1\. To determine the effectiveness of donepezil as compared to placebo for the management of opiate-induced sedation/drowsiness in patients with stable cancer pain Secondary Objectives: 1. To assess the side-effects in both groups of 1 week treatment of 5 mg donepezil and placebo 2. To assess the effects of donepezil on fatigue (FACIT-Fatigue), and other symptoms (Anderson Symptom Assessment Scale) 3. To assess the effects of donepezil on cognition (Symbol Digit Modalities Test) 4. To assess the effects of donepezil on constipation (number of bowel movements)

Timeline

Start
2003-11
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 5 mg Oral

Indications

No indication recorded.